Back
ESC2025 Premium Access

A randomized, open-label study of the efficacy of trimetazidine in preventing acute myocardial injury in patients hospitalized for moderate to severe acute respiratory syndrome caused by SARS-CoV-2

Session: Risk factors: biomarkers
Topic: Biomarkers
Speaker: Doctor F. Gallego Lima (Sao Paulo, BR)
Event: ESC Congress 2025

Congress Presentation

Add to my library

Like

About the speaker

Doctor Felipe Gallego Lima

Heart Institute of the University of Sao Paulo (InCor), Sao Paulo (Brazil)
0 follower

3 more presentations in this session

Microvascular function vs. blood pressure in different clinical and non-clinical settings

Speaker: Mr A. Hashemi (Tehran, IR)

Access
Abstract
Slides
Video
Like
Thumbnail

Pulse wave velocity progression determinants: no significant association with novel lipid parameters

Speaker: Doctor M. Bellomare (Milan, IT)

Access
Abstract
Slides
Video
Like
Thumbnail

Salivary hydrogen peroxide as a predictor of atherosclerotic coronary artery disease in diabetic patients, smokers, and diabetic smokers

Speaker: Associate Professor I. Shehata (Zagazig, EG)

Access
Abstract
Slides
Video
Like
Thumbnail

Access the full session

Risk factors: biomarkers

Speakers: Doctor F. Gallego Lima, Mr A. Hashemi, Doctor M. Bellomare, Associate Professor I. Shehata
Access
Like
Thumbnail

About the event

Image

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources